Home » Topics » Regulatory » Patents

Patents
RSS

CRTH2 receptor antagonists in early development at Argenta Discovery

Sep. 1, 2009

High Point Pharmaceuticals discloses inhibitors of TNF-alpha production and PDE4

Sep. 1, 2009

Hong Kong University of Science and Technology describes novel NMDA antagonists

Sep. 1, 2009

Institut Pasteur, CNRS, INSERM design novel anti-HIV inhibitors

Sep. 1, 2009

University of Sydney claims new series of translocator protein ligands

Sep. 1, 2009

Novel antimalarials reported by the Instituto Nacional de Pesquisas da Amazonia

Sep. 1, 2009

Dainippon Sumitomo Pharma patents DPP IV inhibitors for diabetes

Aug. 31, 2009

Novel ZAP-70 inhibitors reported to be in early development at Cellzome

Aug. 31, 2009

Taisho developing mGlu5 receptor antagonists for anxiety

Aug. 31, 2009

French scientists disclose bisphosphonate-based vectors for targeting bone tissue

Aug. 31, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...